Company news

Arcturus Therapeutics Holdings Inc. news in 2026

Arcturus Therapeutics Holdings Inc.'s news releases, calls and decks from 2026, newest first.

View company

Arcturus Therapeutics Announces $50 Million Investment by Meiji Seika Pharma as Part of Expanded Collaboration

November 16, 2026

Arcturus Therapeutics Announces Third Quarter 2026 Financial Results and Pipeline Progress

November 5, 2026

Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 5, 2026

October 26, 2026

Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform

September 23, 2026

Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform

September 18, 2026

Arcturus Therapeutics to Participate in Upcoming Investor Conferences

August 31, 2026

Arcturus Therapeutics Announces Second Quarter 2026 Financial Results and Pipeline Progress

August 6, 2026

Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026

July 27, 2026

Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference

July 20, 2026

Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis

July 1, 2026

Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference

May 26, 2026

Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress

May 7, 2026

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026

April 27, 2026

Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress

March 3, 2026

Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026

February 17, 2026

Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 8, 2026

Calls in 2026

Decks in 2026